GLAXOSMITH Stock Overview
GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
GlaxoSmithKline Consumer Nigeria Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₦17.00 |
| 52 Week High | ₦17.05 |
| 52 Week Low | ₦6.00 |
| Beta | 0.15 |
| 11 Month Change | 1.19% |
| 3 Month Change | 5.92% |
| 1 Year Change | 165.63% |
| 33 Year Change | 144.60% |
| 5 Year Change | 41.67% |
| Change since IPO | 290.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| GLAXOSMITH | NG Pharmaceuticals | NG Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -0.04% |
| 1Y | 165.6% | -1.9% | 52.7% |
Return vs Industry: GLAXOSMITH exceeded the NG Pharmaceuticals industry which returned 17.5% over the past year.
Return vs Market: GLAXOSMITH exceeded the NG Market which returned 108.1% over the past year.
Price Volatility
| GLAXOSMITH volatility | |
|---|---|
| GLAXOSMITH Average Weekly Movement | 2.0% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in NG Market | 9.4% |
| 10% least volatile stocks in NG Market | 3.0% |
Stable Share Price: GLAXOSMITH's share price has been volatile over the past 3 months.
Volatility Over Time: GLAXOSMITH's weekly volatility has decreased from 7% to 2% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | 51 | Olakunle Oyelana | www.gsk.com/ng |
GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes of consumer healthcare and pharmaceutical products in Nigeria, Africa, the Middle East, the Americas, the Asia Pacific, and Europe. It operates through two segments, Consumer Healthcare and Pharmaceuticals. The Consumer Healthcare segment offers oral care, over the counter (OTC) medicines, and nutritional healthcare products.
GlaxoSmithKline Consumer Nigeria Plc Fundamentals Summary
| GLAXOSMITH fundamental statistics | |
|---|---|
| Market cap | ₦20.33b |
| Earnings (TTM) | ₦735.69m |
| Revenue (TTM) | ₦15.85b |
27.6x
P/E Ratio1.3x
P/S RatioIs GLAXOSMITH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GLAXOSMITH income statement (TTM) | |
|---|---|
| Revenue | ₦15.85b |
| Cost of Revenue | ₦10.62b |
| Gross Profit | ₦5.23b |
| Other Expenses | ₦4.49b |
| Earnings | ₦735.69m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 33.00% |
| Net Profit Margin | 4.64% |
| Debt/Equity Ratio | 0% |
How did GLAXOSMITH perform over the long term?
See historical performance and comparison